We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$13.7B
AUM Growth
+$3.66B
Cap. Flow
+$2.6B
Cap. Flow %
18.96%
Top 10 Hldgs %
51.2%
Holding
3,395
New
1,045
Increased
548
Reduced
607
Closed
1,119

Sector Composition

Rank Sector Weight
1 Technology 8.67%
2 Consumer Discretionary 5.65%
3 Financials 5.29%
4 Healthcare 4.91%
5 Materials 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNAVW
2001
DELISTED
NextNav Inc Warrant
NNAVW
$31K ﹤0.01%
43,940
FSR
2002
PUT
DELISTED
Fisker Inc.
FSR
$31K ﹤0.01%
+18,100
New +$64K
CKPT
2003
DELISTED
Checkpoint Therapeutics
CKPT
$30K ﹤0.01%
+13,405
New +$29.2K
LVWR.WS icon
2004
LiveWire Group Warrants
LVWR.WS
$5.09M
$30K ﹤0.01%
74,933
+10
+0% +$3
BKSY icon
2005
BlackSky Technology
BKSY
$1.19B
$29K ﹤0.01%
+2,641
New +$26.8K
SMR.WS
2006
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$29K ﹤0.01%
96,648
+2,327
+2% +$972
PRZO icon
2007
ParaZero Technologies
PRZO
$14.4M
$28K ﹤0.01%
39,658
-5,459
-12% -$6.82K
USBC
2008
USBC Inc
USBC
$132M
$27K ﹤0.01%
1,330
+1,036
+352% +$16.3K
MSPRW
2009
DELISTED
MSP Recovery Inc Warrant
MSPRW
$27K ﹤0.01%
7,412,754
-1,848,937
-20% -$10.7K
WBUY
2010
DELISTED
WEBUY GLOBAL LTD. Ordinary Shares
WBUY
$27K ﹤0.01%
+53,977
New +$196K
SVMH
2011
DELISTED
SRIVARU Holding Limited Ordinary Shares
SVMH
$27K ﹤0.01%
+1,558
New +$34.2K
AMLI
2012
DELISTED
American Lithium Corp. Common Stock
AMLI
$27K ﹤0.01%
+24,728
New +$29.1K
BCEL
2013
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$27K ﹤0.01%
+206,842
New +$48.5K
NSTG
2014
DELISTED
NanoString Technologies, Inc.
NSTG
$27K ﹤0.01%
+36,134
New +$38.2K
CMRX
2015
DELISTED
Chimerix, Inc.
CMRX
$26K ﹤0.01%
+27,036
New +$26.2K
NXTP
2016
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$26K ﹤0.01%
+11,374
New +$9.57K
ASMB icon
2017
Assembly Biosciences
ASMB
$529M
$25K ﹤0.01%
+2,543
New +$24.2K
CLDI icon
2018
Calidi Biotherapeutics
CLDI
$3.96M
$25K ﹤0.01%
9
+4
+80% +$17.2K
AIIOW
2019
Robo.ai Inc Warrant
AIIOW
$436K
$25K ﹤0.01%
156,549
ORMP icon
2020
Oramed Pharmaceuticals
ORMP
$179M
$25K ﹤0.01%
+11,165
New +$23.8K
JXG
2021
JX Luxventure
JXG
$96M
$25K ﹤0.01%
313
-199
-39% -$15.8K
FABC
2022
Fabric.AI Inc
FABC
$18.4M
$24K ﹤0.01%
+887
New +$26.9K
DRUG
2023
Bright Minds Biosciences
DRUG
$778M
$24K ﹤0.01%
16,845
+3,475
+26% +$4.96K
WALDW icon
2024
Waldencast PLC Warrant
WALDW
$4.21M
$24K ﹤0.01%
24,970
SCPX
2025
DELISTED
Scorpius Holdings, Inc.
SCPX
$24K ﹤0.01%
+14
New +$22.4K

Similar funds

HRT Financial's Q4 2023 Portfolio in Review

As of Q4 2023, HRT Financial held 3,395 positions worth $13.7B, up 37% from $10B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

HRT Financial deployed $2.6B of net new capital in Q4 2023, opening 1,045 new positions and adding to 548 existing holdings. Its largest new stake was Linde: 727,095 shares worth $299M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $83.7M trimmed.

  • HRT Financial's largest Q4 2023 buy was Linde: 727,095 shares worth $299M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.94B increase.
  • HRT Financial's biggest Q4 2023 reduction was Broadcom, cutting an estimated $83.7M.
  • HRT Financial fully exited Newmont in Q4 2023, selling an estimated $140M.
  • HRT Financial's ten largest holdings make up 51% of its $13.7B portfolio in Q4 2023.
  • HRT Financial opened 1,045 new positions and closed 1,119 in Q4 2023.
  • HRT Financial's portfolio value rose 37% quarter-over-quarter to $13.7B.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.